PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To study the radioactive uptake of [68Ga]P137 in the lesion sites of PCa patients and
evaluate the ability of [68Ga]P137 to detect PSMA overexpression in PCa patients (especially
those with recurrent or advanced PCa).